Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in paediatric subjects: An analysis by age group.
Hyoung Jin KangSusan LoftusCara DiCristinaStuart GreenAnnpey PongChristian Michel ZwaanPublished in: Pediatric blood & cancer (2018)
A 3 day aprepitant regimen seemed effective and safe for prevention of chemotherapy-induced nausea and vomiting in paediatric subjects across subgroups (ClinicalTrials.gov NCT01362530).